Join Growin Stock Community!

Basel medical group ltd ordinary sharesBMGL.US Overview

US StockHealthcare
(No presentation for BMGL)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

BMGL AI Insights

BMGL Overall Performance

BMGL AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

BMGL Recent Performance

2.62%

Basel medical group ltd ordinary shares

0.05%

Avg of Sector

-0.31%

S&P500

BMGL PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

BMGL Key Information

BMGL Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

BMGL Profile

Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.

Price of BMGL

BMGL FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

BMGL Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.93
PB Ratio
2.95
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.93
PB Ratio
2.95
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is BMGL's latest earnings report released?

    The most recent financial report for Basel medical group ltd ordinary shares (BMGL) covers the period of 2024Q4 and was published on 2024/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating BMGL's short-term business performance and financial health. For the latest updates on BMGL's earnings releases, visit this page regularly.

  • How much cash does BMGL have?

    At the end of the period, Basel medical group ltd ordinary shares (BMGL) held Total Cash and Cash Equivalents of 7.45M, accounting for 0.5 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.